MedPath

REOPRO

REOPRO

Discontinued
DIN Number

02216973

Drug Class

Human

Market Date

Oct 30, 1996

Company
HC

Janssen Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02216973
AIG Number0128572001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
B01AC13 ABCIXIMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification92:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

ABCIXIMABActive
Strength: 2 MG / ML
Monograph: ABCIXIMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.